You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Controlling Nosocomial Infection

Everyone Is Concerned

Arch Dermatol. 2000;136:785-786.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN 1985, a report from the Study on the Efficacy of Nosocomial Infection Control Project,1 a large multicenter surveillance system of nosocomial infections, estimated that at least 2.1 million hospital-acquired infections occurred per year among 37.7 million admissions in US hospitals, and 77,000 deaths were associated with nosocomial infections.2 These data, combined with the concomitant growing emergence of multiresistant bacteria, justified the implementation of infection control policies in hospitals.

Many studies in the field of epidemiology and prevention of nosocomial infections have been conducted in intensive care units (ICUs), which are characterized by the highest rates of nosocomial infections among all hospital facilities. Intensive care units are also where the most severely ill patients are treated and the highest mortality rates occur. The latter occurrence results from the acute severity of illness of patients treated in the ICU, and the rate of nosocomial infection is primarily explained by frequent exposure . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Methicillin-Resistant Staphylococcus aureus Nosocomial Acquisition and Carrier State in a Wound Care Center
Guillaume Kac, Annie Buu-Hoï, Elisabeth Hérisson, Patricia Biancardini, and Clélia Debure
Arch Dermatol. 2000;136(6):735-739.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.